Literature DB >> 16401322

Factors associated with insulin discontinuation in subjects with ketosis-prone diabetes but preserved beta-cell function.

M R Maldonado1, M E Otiniano, F Cheema, L Rodriguez, A Balasubramanyam.   

Abstract

AIM: To evaluate factors predictive of insulin discontinuation in subjects with ketosis-prone Type 2 diabetes.
METHODS: One hundred and six subjects with ketosis-prone Type 2 diabetes were recruited during the index episode of diabetic ketoacidosis (DKA). All subjects were followed in a special clinic for at least 6 months. If the subject's glycaemic control reached specified glycaemic goals, exogenous insulin was gradually decreased until discontinuation. Baseline and follow-up characteristics were compared between the off-insulin and the on-insulin groups.
RESULTS: At the end of the follow-up period (915+/-375 days) insulin was discontinued in 47% subjects. Subjects in the off-insulin group were significantly older at the time of diagnosis of diabetes. In the off-insulin group the majority of subjects were newly diagnosed with diabetes. After 6 months of follow-up, subjects in the off-insulin group had significantly lower mean HbA(1c), higher mean C-peptide-to-glucose ratio and had more clinic visits per year. In the proportional hazard analysis, new-onset diabetes [hazard ratio (HR) 1.54; 95% confidence interval (CI) 1.02-2.45], and a higher C-peptide-to-glucose ratio at 6 months of follow-up (HR 1.77; 95% CI 1.22-2.63) were significant predictors of insulin discontinuation.
CONCLUSIONS: In subjects with ketosis-prone Type 2 diabetes, the best predictors of insulin discontinuation are having new-onset diabetes, and higher beta-cell functional reserve (as measured by the C-peptide-to-glucose ratio).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16401322     DOI: 10.1111/j.1464-5491.2005.01724.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  15 in total

Review 1.  Approach to the patient with atypical diabetes.

Authors:  Devin W Steenkamp; Sara M Alexanian; Elliot Sternthal
Journal:  CMAJ       Date:  2014-01-06       Impact factor: 8.262

2.  Male predominance in ketosis-prone diabetes mellitus.

Authors:  Xiaohao Wang; Huiwen Tan
Journal:  Biomed Rep       Date:  2015-05-08

Review 3.  Syndromes of ketosis-prone diabetes mellitus.

Authors:  Ashok Balasubramanyam; Ramaswami Nalini; Christiane S Hampe; Mario Maldonado
Journal:  Endocr Rev       Date:  2008-02-21       Impact factor: 19.871

4.  β- and α-cell dysfunctions in africans with ketosis-prone atypical diabetes during near-normoglycemic remission.

Authors:  Siméon-Pierre Choukem; Eugene Sobngwi; Philippe Boudou; Lila-Sabrina Fetita; Raphael Porcher; Fidaa Ibrahim; Bertrand Blondeau; Patrick Vexiau; Franck Mauvais-Jarvis; Fabien Calvo; Jean-François Gautier
Journal:  Diabetes Care       Date:  2012-08-28       Impact factor: 19.112

5.  Pathogenesis of A⁻β⁺ ketosis-prone diabetes.

Authors:  Sanjeet G Patel; Jean W Hsu; Farook Jahoor; Ivonne Coraza; James R Bain; Robert D Stevens; Dinakar Iyer; Ramaswami Nalini; Kerem Ozer; Christiane S Hampe; Christopher B Newgard; Ashok Balasubramanyam
Journal:  Diabetes       Date:  2012-11-16       Impact factor: 9.461

6.  Ketosis-onset diabetes and ketosis-prone diabetes: same or not?

Authors:  Beiyan Liu; Changhua Yu; Qiang Li; Lin Li
Journal:  Int J Endocrinol       Date:  2013-04-23       Impact factor: 3.257

7.  HLA class II alleles susceptibility markers of type 1 diabetes fail to specify phenotypes of ketosis-prone diabetes in adult Tunisian patients.

Authors:  Lilia Laadhar; Fatma Harzallah; Mondher Zitouni; Maryam Kallel-Sellami; Moncef Fekih; Naziha Kaabachi; Hádia Slimane; Sondès Makni
Journal:  Exp Diabetes Res       Date:  2011-03-02

8.  Diabetes 1.5: Ketone-Prone Diabetes.

Authors:  Sabina B Safder; Rami Mortada
Journal:  Clin Diabetes       Date:  2015-07

Review 9.  The clinical utility of C-peptide measurement in the care of patients with diabetes.

Authors:  A G Jones; A T Hattersley
Journal:  Diabet Med       Date:  2013-07       Impact factor: 4.359

10.  Ketosis onset type 2 diabetes had better islet β-cell function and more serious insulin resistance.

Authors:  Hongyun Lu; Fang Hu; Yingjuan Zeng; Lingling Zou; Shunkui Luo; Ying Sun; Hong Liu; Liao Sun
Journal:  J Diabetes Res       Date:  2014-04-13       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.